MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

16.39 0.49

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.05

Максимум

16.7

Ключови измерители
By Trading Economics
Приходи	10M -33M
Продажби	-435K 54M
Марж на печалбата	-60.369
Служители	891
EBITDA	10M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+30.02% upside

Дивиденти
By Dow Jones
Следващи печалби	25.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-276M 1.2B
Предишно отваряне	15.9
Предишно затваряне	16.39

Настроения в новините

By Acuity

50%

177 / 360 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.01.2026 г., 23:49 ч. UTC

Значими двигатели на пазара

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21.01.2026 г., 21:12 ч. UTC

Значими двигатели на пазара

Automaker Stocks Rise After Trump Calls Off European Tariffs

21.01.2026 г., 21:00 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21.01.2026 г., 20:29 ч. UTC

Значими двигатели на пазара

Chip Makers Gain After Trump Calls Off European Tariffs

21.01.2026 г., 20:04 ч. UTC

Значими двигатели на пазара

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21.01.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21.01.2026 г., 22:39 ч. UTC

Печалби

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

21.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.01.2026 г., 21:35 ч. UTC

Придобивния, сливания и поглъщания

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21.01.2026 г., 21:19 ч. UTC

Печалби

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21.01.2026 г., 20:45 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Borse Group to Acquire Allfunds for $6.19B

21.01.2026 г., 20:36 ч. UTC

Пазарно говорене

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21.01.2026 г., 20:31 ч. UTC

Пазарно говорене

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21.01.2026 г., 20:27 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21.01.2026 г., 20:27 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

21.01.2026 г., 20:27 ч. UTC

Пазарно говорене

Was It a 'TACO' Event? -- Market Talk

21.01.2026 г., 20:26 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21.01.2026 г., 20:23 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21.01.2026 г., 20:21 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21.01.2026 г., 20:19 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse Group Agrees to Buy Allfunds

21.01.2026 г., 20:08 ч. UTC

Печалби

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21.01.2026 г., 20:03 ч. UTC

Пазарно говорене

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21.01.2026 г., 19:51 ч. UTC

Пазарно говорене

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21.01.2026 г., 19:43 ч. UTC

Пазарно говорене

U.S. Ethanol Production Expected to Slip -- Market Talk

21.01.2026 г., 19:31 ч. UTC

Пазарно говорене

Gold Settles at Fresh All-Time High -- Market Talk

21.01.2026 г., 19:24 ч. UTC

Печалби

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21.01.2026 г., 19:10 ч. UTC

Пазарно говорене

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21.01.2026 г., 18:57 ч. UTC

Пазарно говорене

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

30.02% нагоре

12-месечна прогноза

Среден 21.83 USD 30.02%

Висок 25 USD

Нисък 18 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

7 ratings

Купи

Задържане

Продай

Според 7 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

177 / 360 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.